Stock Earnings

Question 1

What are BeOne Medicines AG's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), BeOne Medicines AG has a total asset of $42,834, Net loss of $-4,978

Question 2

What are the key financial ratios for ONC?

Accepted Answer

BeOne Medicines AG's Current ratio is 2.29, has a Net margin is -18.29, sales per share of $19.89.

Question 3

How is BeOne Medicines AG's revenue broken down by segment or geography?

Accepted Answer

BeOne Medicines AG largest revenue segment is Collaboration, at a revenue of 30,695,000 in the most earnings release.For geography, U.S. is the primary market for BeOne Medicines AG, at a revenue of 1,957,498,000.

Question 4

Is BeOne Medicines AG profitable?

Accepted Answer

no, according to the latest financial statements, BeOne Medicines AG has a net loss of $-4,978

Question 5

Does BeOne Medicines AG have any liabilities?

Accepted Answer

yes, BeOne Medicines AG has liability of 18,659

Question 6

How many outstanding shares for BeOne Medicines AG?

Accepted Answer

BeOne Medicines AG has a total outstanding shares of 1,387.36

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	35,673	27,213	17,423	9,566	7,588	2,120
Revenue Growth (YoY)	51%	56%	82%	26%	258%	-28%
Cost of Revenue	4,997	4,263	2,710	1,903	1,061	485
Gross Profit	30,675	22,950	14,713	7,663	6,527	1,634
Selling, General & Admin	14,684	13,254	10,860	8,769	6,588	4,134
Research & Development	15,133	13,554	12,450	10,825	9,189	8,662
Operating Expenses	29,655	27,192	23,463	19,688	15,996	12,996
Other Non Operating Income (Expenses)	-1	0	2,601	-1	0	-2
Pretax Income	791	-4,162	-6,208	-13,426	-9,579	-11,248
Income Tax Expense	944	815	507	215	168	158
Net Income	-152	-4,978	-6,715	-13,642	-9,747	-11,383
Net Income Growth	-98%	-26%	-51%	40%	-14%	65%
Shares Outstanding (Diluted)	1,534.25	1,367.66	1,356.73	1,340.08	1,334.8	1,334.78
Shares Change (YoY)	12%	1%	1%	0%	0%	0%
EPS (Diluted)	-0.09	-3.64	-4.95	-10.18	-7.3	-8.52
EPS Growth	-98%	-26%	-51%	39%	-14%	65%
Free Cash Flow	3,318	-4,677	-11,899	-10,134	-10,541	-6,171
Free Cash Flow Per Share	2.16	-3.41	-8.77	-7.56	-7.89	-4.62
Gross Margin	85.98%	84.33%	84.44%	80.1%	86.01%	77.07%
Operating Margin	2.85%	-15.58%	-50.22%	-125.7%	-124.77%	-535.94%
Profit Margin	-0.42%	-18.29%	-38.54%	-142.6%	-128.45%	-536.93%
Free Cash Flow Margin	9.3%	-17.18%	-68.29%	-105.93%	-138.91%	-291.08%
EBITDA	--	-3,656	-8,387	-11,699	-9,119	-11,015
EBITDA Margin	--	-13.43%	-48.13%	-122.29%	-120.17%	-519.57%
D&A For EBITDA	--	585	363	326	349	347
EBIT	1,020	-4,241	-8,750	-12,025	-9,468	-11,362
EBIT Margin	2.85%	-15.58%	-50.22%	-125.7%	-124.77%	-535.94%
Effective Tax Rate	119.34%	-19.58%	-8.16%	-1.6%	-1.75%	-1.4%

BeOne Medicines AG (ONC) Price

ONC Stock Price Chart

ONC Income

Follow-Up Questions